Director at Journey Medical (DERM) receives 10,000 restricted stock units

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Smith Justin Adam reported acquisition or exercise transactions in this Form 4 filing.

Journey Medical Corp director Justin Adam Smith received a grant of 10,000 shares of common stock as restricted stock units on June 25, 2026. These units were issued under the company’s 2015 Stock Plan and will vest as 10,000 shares on June 25, 2027.

After this equity award, Smith’s direct holdings total 181,618 shares, including restricted stock units that vest over various time periods. This is a compensation-related equity grant rather than an open-market share purchase or sale.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Smith Justin Adam

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock, $0.0001 par value	10,000	$0.00	--

Holdings After Transaction: Common Stock, $0.0001 par value — 181,618 shares (Direct, null)

Footnotes (1)

On June 25, 2026, the reporting person was granted 10,000 restricted stock units pursuant to the Issuer's 2015 Stock Plan, as amended, which will vest in accordance with the following schedule: 10,000 shares on June 25, 2027. Includes restricted stock units, which vest over various time periods.

Key Figures

RSU grant size: 10,000 shares Grant price per share: $0.0000 per share Holdings after transaction: 181,618 shares +1 more

4 metrics

RSU grant size 10,000 shares Restricted stock units granted June 25, 2026

Grant price per share $0.0000 per share Equity award under 2015 Stock Plan

Holdings after transaction 181,618 shares Direct ownership following June 25, 2026 grant

Vesting date June 25, 2027 10,000 RSUs vest into common shares

Key Terms

restricted stock units, 2015 Stock Plan, vest, Common Stock, $0.0001 par value

4 terms

restricted stock units financial

"the reporting person was granted 10,000 restricted stock units pursuant to the Issuer's 2015 Stock Plan"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

2015 Stock Plan financial

"granted 10,000 restricted stock units pursuant to the Issuer's 2015 Stock Plan, as amended"

vest financial

"which will vest in accordance with the following schedule: 10,000 shares on June 25, 2027"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

Common Stock, $0.0001 par value financial

"security_title: Common Stock, $0.0001 par value"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 06/26/2026 - 04:21 PM Accepted by SEC EDGAR 06/26/2026 - 04:20 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Smith Justin Adam

(Last)

(First)

(Middle)

C/O JOURNEY MEDICAL CORPORATION

9237 E VIA DE VENTURA BLVD., SUITE 105

(Street)

SCOTTSDALE

ARIZONA

85258

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Journey Medical Corp [ DERM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/25/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock, $0.0001 par value	06/25/2026		A		10,000⁽¹⁾	A	$0	181,618⁽²⁾	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. On June 25, 2026, the reporting person was granted 10,000 restricted stock units pursuant to the Issuer's 2015 Stock Plan, as amended, which will vest in accordance with the following schedule: 10,000 shares on June 25, 2027.

2. Includes restricted stock units, which vest over various time periods.

	/s/ Ramsey Alloush, attorney-in-fact	06/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Journey Medical (DERM) report for Justin Adam Smith?

Journey Medical reported that director Justin Adam Smith received 10,000 restricted stock units on June 25, 2026. The grant is a stock-based compensation award under the 2015 Stock Plan, not an open-market purchase or sale of existing shares.

How many Journey Medical (DERM) shares does Justin Adam Smith hold after this grant?

After the June 25, 2026 grant, Justin Adam Smith holds 181,618 Journey Medical shares directly. This total includes restricted stock units that vest over various time periods, reflecting both currently owned shares and unvested equity awards.

When do the newly granted Journey Medical (DERM) restricted stock units vest?

The 10,000 restricted stock units granted on June 25, 2026 are scheduled to vest on June 25, 2027. Vesting means the units convert into Journey Medical common shares, subject to the terms of the 2015 Stock Plan and any applicable service conditions.

Was cash paid for the 10,000 Journey Medical (DERM) shares received by Justin Adam Smith?

No cash was paid for these 10,000 shares; the Form 4 shows a price per share of $0.0000. The shares were granted as restricted stock units under the company’s 2015 Stock Plan as part of equity compensation for the director.

Is the Journey Medical (DERM) Form 4 transaction a buy or sell signal?

This Form 4 reflects an equity award, not a discretionary buy or sell. The transaction is coded as a grant or award acquisition, meaning the director received restricted stock units as compensation rather than trading shares in the open market.